142 related articles for article (PubMed ID: 9675642)
1. Candidate targets for hepatitis C virus-specific antiviral therapy.
Bartenschlager R
Intervirology; 1997; 40(5-6):378-93. PubMed ID: 9675642
[TBL] [Abstract][Full Text] [Related]
2. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
[TBL] [Abstract][Full Text] [Related]
3. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.
Morikawa K; Lange CM; Gouttenoire J; Meylan E; Brass V; Penin F; Moradpour D
J Viral Hepat; 2011 May; 18(5):305-15. PubMed ID: 21470343
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus RNA replication depends on specific cis- and trans-acting activities of viral nonstructural proteins.
Kazakov T; Yang F; Ramanathan HN; Kohlway A; Diamond MS; Lindenbach BD
PLoS Pathog; 2015 Apr; 11(4):e1004817. PubMed ID: 25875808
[TBL] [Abstract][Full Text] [Related]
5. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo.
Kolykhalov AA; Mihalik K; Feinstone SM; Rice CM
J Virol; 2000 Feb; 74(4):2046-51. PubMed ID: 10644379
[TBL] [Abstract][Full Text] [Related]
7. Processing pathways of the hepatitis C virus proteins.
Lohmann V; Koch JO; Bartenschlager R
J Hepatol; 1996; 24(2 Suppl):11-9. PubMed ID: 8836884
[TBL] [Abstract][Full Text] [Related]
8. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
9. The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy.
Bartenschlager R
J Viral Hepat; 1999 May; 6(3):165-81. PubMed ID: 10607229
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines.
De Francesco R; Neddermann P; Tomei L; Steinkühler C; Gallinari P; Folgori A
Semin Liver Dis; 2000; 20(1):69-83. PubMed ID: 10895433
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics.
Lin C; Prágai BM; Grakoui A; Xu J; Rice CM
J Virol; 1994 Dec; 68(12):8147-57. PubMed ID: 7966606
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus NS2/3 protease regulates HCV IRES-dependent translation and NS5B RdRp activity.
She Y; Han T; Ye L; Wu Z
Arch Virol; 2009; 154(9):1465-73. PubMed ID: 19688585
[TBL] [Abstract][Full Text] [Related]
13. Kinetic and structural analyses of hepatitis C virus polyprotein processing.
Bartenschlager R; Ahlborn-Laake L; Mous J; Jacobsen H
J Virol; 1994 Aug; 68(8):5045-55. PubMed ID: 8035505
[TBL] [Abstract][Full Text] [Related]
14. Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance.
Mathy JE; Ma S; Compton T; Lin K
Antimicrob Agents Chemother; 2008 Sep; 52(9):3267-75. PubMed ID: 18591281
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1.
Duong FH; Christen V; Berke JM; Penna SH; Moradpour D; Heim MH
J Virol; 2005 Dec; 79(24):15342-50. PubMed ID: 16306605
[TBL] [Abstract][Full Text] [Related]
16. The nonstructural proteins of the hepatitis C virus: structure and functions.
Neddermann P; Tomei L; Steinkühler C; Gallinari P; Tramontano A; De Francesco R
Biol Chem; 1997 Jun; 378(6):469-76. PubMed ID: 9224925
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.
Wu JZ; Yao N; Walker M; Hong Z
Mini Rev Med Chem; 2005 Dec; 5(12):1103-12. PubMed ID: 16375756
[TBL] [Abstract][Full Text] [Related]
18. Determination of Critical Requirements for Classical Swine Fever Virus NS2-3-Independent Virion Formation.
Dubrau D; Schwindt S; Klemens O; Bischoff H; Tautz N
J Virol; 2019 Sep; 93(18):. PubMed ID: 31292243
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
[TBL] [Abstract][Full Text] [Related]
20. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay.
Lin C; Rice CM
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7622-6. PubMed ID: 7644466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
